In addition, cytokine-activated NK cells with upregulated NCRs and NKG2D are partly able to overcome tumor immune escape by restoring NKG2D-mediated NK cell cytotoxicity via scavenging of plasma MICA as demonstrated for neuroblastoma and head and neck cancer, respectively (124, 132). This evidence concerns the gene MICA and neoplasm.